TALTZ

125521 | Orange Book

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed March 22, 2016
Ingredients IXEKIZUMAB
Dosage Form / Route INJECTABLE and INJECTION
Patents No unexpired patents
Last Updated: 2 years, 5 months ago
Date Patent / Filing No. Patent and Drug Application Information
7/27/2022SUPPL-24Supplement:
5/4/2022SUPPL-23Supplement: Label is not available on this site.
    3/10/2021SUPPL-14Supplement:
    5/29/2020SUPPL-19Supplement:
    3/26/2020SUPPL-20Supplement:
    8/23/2019SUPPL-16Supplement:
    5/17/2018SUPPL-9Supplement:
    4/19/2018SUPPL-2Supplement:
    3/16/2018SUPPL-11Supplement: Label is not available on this site.
    12/1/2017SUPPL-4Supplement:
    7/5/2017SUPPL-3Supplement:
    3/22/2016ORIG-1Approval:
    Approval for TALTZ, 80MG/ML
    • Active Ingredient: IXEKIZUMAB
    • Dosage Form: INJECTABLE
    • Dosage Route: INJECTION
    • Therapeutic Equivalence: